Mesa LaboratoriesMLAB
Market Cap: $667M
About: Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Employees: 736
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0% more funds holding
Funds holding: 154 [Q1] → 154 (+0) [Q2]
0% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 25
4.17% less ownership
Funds ownership: 94.94% [Q1] → 90.77% (-4.17%) [Q2]
24% less capital invested
Capital invested by funds: $562M [Q1] → $425M (-$137M) [Q2]
31% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 61
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Wells Fargo Brandon Couillard 55% 1-year accuracy 6 / 11 met price target | 3%downside $120 | Underweight Initiated | 27 Aug 2024 |
Evercore ISI Group Vijay Kumar 90% 1-year accuracy 27 / 30 met price target | 3%downside $120 | Outperform Maintained | 6 Aug 2024 |
Evercore ISI Group Vijay Kumar 90% 1-year accuracy 27 / 30 met price target | 14%downside $106 | Outperform Maintained | 2 Jul 2024 |
Financial journalist opinion
Based on 3 articles about MLAB published over the past 30 days